CIK 0001645113 · Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- operating
- Phone
- 44 (0)15 3475 6700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- 4 Open-market sale Chief Operating Officer sold 3,079 shares at $12.86 ($39,602)
- 4 Open-market sale Chief Financial Officer sold 7,343 shares at $12.86 ($94,446)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- 4 Insider Changes in Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Other events
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Regulation FD disclosure
Page 1 of 59 · 1,179 filings